For Thyroid Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.
For Thyroid Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space:
After it produced a 75% overall response rate across a range of tumor types, including thyroid cancer, Vitrakvi was approved by the Food and Drug Administration for the treatment of patients with NTRK fusions.
Instead of undergoing surgery for potential cancer, many people with thyroid nodules can safely opt for surveillance.
One patient shared her story about why she thinks her thyroid cancer diagnosis happened for a reason.
For Nicole McGuinness, timing was everything when a friend told her a surgeon from nearly 500 miles away was looking for her after spotting a lump on her neck that turned out to be thyroid cancer — when he saw her on the HGTV show “Beachfront Bargain Hunt.”
The first anaplastic thyroid cancer drug in 50 years was approved earlier this year — learn more about it in this roundup of the biggest rare cancer updates from the American Society of Clinical Oncology.